70 In the index

Adrafinil ADRA

A compound the liver converts into modafinil, a prescription drug that promotes wakefulness. Since modafinil itself is well studied and helps people stay alert, adrafinil should work similarly, but it puts extra strain on the liver and has been linked to elevated liver enzymes with regular use.

Also known as Olmifon, Adrafinilum, adrafinilo, BI81Z4542G, adrafinyl, benzhydrylsulfinylacetohydroxamic acid, RefChem:109836

Effects Focus

Routes Oral

Legal status Unscheduled

WADA Banned in-competition

3D Molecular Structure of C₁₅H₁₅NO₃S

Drag to rotate · scroll to zoom

Chemistry

Formula: C15H15NO3S
Molar mass: 289.4
CAS: 63547-13-7
PubChem CID: 3033226
IUPAC name: 2-benzhydrylsulfinyl-N-hydroxyacetamide
InChIKey: CGNMLOKEMNBUAI-UHFFFAOYSA-N

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 300 mg

Reported range 150-300 mg/day

Route Oral

Frequency Once daily (morning)

Duration Intermittent use recommended; not intended for continuous daily long-term use

Not FDA-approved; converted to modafinil in the liver. Chronic use has been linked to elevated liver enzymes.

Where this comes from Limited clinical pharmacology studies; consumer nootropic literature

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.